|
Prescription Drug Search
Strengths available for Zomig:
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about MyGlobalPharmacy.com
List of countries where we can ship Zomig:
- Algeria
- Anguilla
- Aruba
- Austria
- Belgium
- Belize
- Bulgaria
- Costa Rica
- Cyprus
- Denmark
- European Union
- Fiji
- Finland
- Germany
- Guadeloupe
- Guatemala
- Hong Kong
- India
- Indonesia
- Italy
- Kuwait
- Lebanon
- Moldova, Republic of
- Panama
- Poland
- Qatar
- Russian Federation
- Saint Lucia
- Saudi Arabia
- Serbia
- South Africa
- Sweden
- Taiwan
- Thailand
- Trinidad and Tobago
- Ukraine
- United Kingdom, UK
- United States, US
- Uruguay
- Vanuatu
Latest news releases on Zomig:
Glenmark Gets USFDA Tentative Nod For Zolmitriptan Orally Disintegrating Tablets - RTT News
(RTTNews) - Glenmark Pharmaceuticals Ltd. said its US subsidiary Glenmark Generics Inc. has obtained tentative approval from US FDA for Zolmitriptan orally disintegrating tablets, its generic version of AstraZeneca's Zomig-ZMT tablets. The tentative ...
Glenmark Generics receives tentative U.S. FDA approval for zolmitriptan orally disintegrating tablets - equitybulls.com
its generic version of AstraZeneca’s Zomig-ZMT® Tablets. The tentative approval is for the 2.5 mg and 5 mg orally disintegrating tablets of zolmitriptan and constitutes one of the first tentative approvals granted by the FDA for a generic ...
Glenmark Generics gets US FDA tentative nod for zolmitriptan tablets - pharmabiz.com
the generic version of AstraZeneca's Zomig-ZMT tablets. The tentative approval is for the 2.5 mg and 5 mg orally disintegrating tablets of zolmitriptan and consitutes one of the first tentative approvals granted by the FDA for a generic vesion of the drug.
Impax Laboratories Reports Adjusted First Quarter 2012 EPS of $0.52; GAAP EPS of $0.18 - Boston Globe
“During the first quarter of 2012, we established the infrastructure to successfully transition the U.S. commercial opportunity for Zomig® from AstraZeneca to our brand division. The transaction was accretive to our first quarter non-GAAP ...
Glenmark gets tentative nod from USFDA for migraine tablets - MSN India
The approval is for zolmitriptan tablets in the strengths of 2.5 mg and 5 mg, Glenmark said. The tablets are generic version of AstraZeneca''s Zomig-ZMT tablets, it added. Earlier in in September 2011, the company had received tentative approval for ...
